Perspective


Colorectal cancer treatment: Is Bevacizumab the best option?

Luca Bagnasco, Daniela Piras

Abstract

Colorectal cancer (CRC) is the third most common neoplastic disease worldwide and the second leading cause of cancer death in the western world (1).